Navigation Links
Did Sun and Taro Under-Report 3rd Quarter Results by Gaming Reserves?
Date:11/5/2012

NEW YORK, Nov. 5, 2012 /PRNewswire/ -- IsZo Capital Management LP, one of the largest minority shareholders of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), announced today that it delivered the following letter to the Special Committee of the Board of Directors of Taro, citing evidence that raises the question of whether Taro's management may be under-reporting Taro's third quarter net sales data by artificially inflating reserves for product returns, chargebacks, rebates and other sales-related items, just a month ahead of the special meeting of Taro shareholders to vote upon the proposed merger with Sun Pharmaceutical Industries Ltd. (BSE: SUNPHARMA) at the grossly inadequate below-market price of $39.50 per Taro share.

Re:
3rd Quarter Financial Results;
Did Taro Under-Report 3rd Quarter Results by Gaming Reserves? Ladies and Gentlemen:

Recently, rumors have been circulating that Taro and Sun were intentionally trying to understate their financial results by over-reserving; all ahead of the special December 6th shareholder meeting to vote upon the Sun merger.  We have been busy using our forensic accounting skills and broad industry knowledge attempting to evaluate the veracity of these rumors.  To our dismay, Taro and Sun delivered such evidence with the reported 3rd quarter financial results; results suspiciously inconsistent with readily available commercial sources of Taro's prescription and sales data.

Taro's reported financials and IMS's reporting of Taro's sales have had nearly perfect correlation over the last year until Taro's 3rd quarter results.  Based on IMS reported data, Taro should have reported net sales of $176.4 mm vs. the $160.9 mm that Taro reported.  So Taro's results are missing roughly $15.4 mm of sales and a similar amount of EBITDA and Profit.  For example, Taro reported QOQ growth of 1% vs.
'/>"/>

SOURCE IsZo Capital Management LP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX Reports Third Quarter 2012 Financial Results
2. Endo Reports Third Quarter Financial Results And Updates 2012 Financial Guidance
3. Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
4. Thoratec Reports Third Quarter Results
5. IRIDEX Reports 2012 Third Quarter Results
6. Masimo Reports Third Quarter 2012 Financial Results; Board Declares Special Cash Dividend of $1.00 per Share
7. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
8. MAP Pharmaceuticals Reports Third Quarter of 2012 Financial Results
9. Halozyme to Host Third Quarter Financial Results Conference Call
10. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
11. PDL BioPharma to Announce Third Quarter 2012 Financial Results on November 5, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... TIJUANA, Mexico , Dec. 24, 2014 /PRNewswire/ ... treatment of its first patient in its study ... to the American Stroke Association, ischemic strokes account ... continues to enroll qualified patients in the study, ... Intravenous Administration of Allogeneic Mesenchymal Stem Cells and ...
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... YORK and LONDON , ... global orthopedic industry are expected to grow at an ... in terms of value and volume. Hip, knee and ... developed world while in emerging economies they have a ... rates are challenging the use of composites. Non-metallic orthopedic ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... Jan. 2, 2012 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... call on Tuesday, January 3, 2012 at 8:30 a.m. Eastern ... ongoing patent litigation with Genentech, Inc., a member of the ... Conference Call InformationDomestic Dial-in Number: (888) 660-6127 International Dial-in Number: ...
... 30, 2011 Four free stock picks are being made ... highlights one Zacks #1 Rank Strong Buy or a Zacks ... styles of investing: Aggressive Growth, Growth & Income, Momentum, and ... The four highlighted picks are: Chemtura Corporation  (NYSE: ...
Cached Medicine Technology:Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation 2Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 2Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 3Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 4
(Date:12/25/2014)... (PRWEB) December 26, 2014 The ... CAGR of 7.2% to reach $5,756.0 million by ... the microscopy market. The electron microscopes product segment ... the forecast period. , Rising focus on nanotechnology, ... growth of the microscopy market. , Get Full ...
(Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... receive effective, less expensive care from a clinic that functions ... of dedicated health care professionals, a new study shows. ... either hospitalization or a trip to the emergency room when ... the University of Texas in Houston versus usual care, according ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the ... the business has introduced its new collection of 2015 ... , The new prom outfits are guaranteed to contain ... They are specially designed for 2015. Anyone who wants ... visit its website before Jan. 26, 2015, the deadline ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... no secret that UVB radiation from the sun causes ... American Journal of PhysiologyRegulatory, Integrative and Comparative Physiology ... formation of wrinkles by lessening tissue damage done by ... were placed in an oxygen chamber after exposure to ...
... studies have found that the personality trait impulsivity, ... behaviors, is associated with alcohol use and alcohol-use ... and young adulthood. Some, however, do not "mature ... have found that individuals who exhibited the largest ...
... ... Coffee Creamers Ready for Distribution to Natural Food Stores and Mainstream Supermarkets Coast-to-Coast. Made ... ... Green Rabbit, LLC, the parent company of MimicCreme®, announced today the release of its ...
... Research Foundation (NRF) of Singapore has announced that the ... universities that have been selected to participate in research ... Excellence and Technological Enterprise) program. The Hebrew ... mechanisms of inflammation. The research aims to accelerate ...
... HealthDay Reporter , MONDAY, June 28 (HealthDay News) ... at helping premenopausal women keep from gaining more weight, a ... pounds off such women who are overweight or obese, said ... the department of nutrition at the Harvard School of Public ...
... , ... cities in the country by the Natural Resources Defense Council. Scottsdale has also seen an ... , ... Scottsdale has been ranked among the greenest cities in the United States by the National ...
Cached Medicine News:Health News:Hyperoxia may slow formation of wrinkles 2Health News:Large decline in impulsivity in early adulthood related to decrease in alcohol consumption 2Health News:MimicCreme Announces the Release of its Dairy-Free Whipping Cream - HealthyTop and Two New Flavored Coffee Creamers. 2Health News:Hebrew University added to Singapore research program 2Health News:A Little Biking May Help Premenopausal Women Stay Slim 2Health News:A Little Biking May Help Premenopausal Women Stay Slim 3Health News:A Little Biking May Help Premenopausal Women Stay Slim 4Health News:Scottsdale Named One of US' Greenest Cities, Green Building Permits on the Rise 2
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
... The BD Directigen EZ RSV Test utilizes ... reagent and one device for rapid RSV detection. ... a method whereby dried reagents have already ... reduced to a two-step process, with clear-cut results ...
Medicine Products: